Historically, convalescent plasma has been used to prevent or treat new viral diseases when other treatments or vaccines were not available. People who have fully recovered from COVID-19 have antibodies in their plasma that can work against the virus.

The plasma obtained from the blood of people who recovered from COVID-19 (convalescent plasma) is being evaluated as treatment for patients with serious or immediately life-threatening COVID-19 infections or those judged by a health care provider to be at high risk of progression to severe or life-threatening disease. Blood specimens may also be used to better understand patients’ immune responses to COVID-19 to assist development of new therapies and vaccines.

Those who are fully recovered from a verified coronavirus (COVID-19) diagnosis can contact the health care institution in their area to be evaluated for eligibility. These are unpaid, voluntary donations.

Interested candidates are encouraged to reach out to the nearest participating provider for instructions. More partners are expected to be added to this project in the coming days and weeks.

See the American Red Cross’s frequently asked questions about the COVID-19 convalescent plasma program. More information can also be found at the National COVID-19 Convalescent Plasma Project website and the American Association of Blood Banks website.